Greenwich LifeSciences Inc Made Headway
Thu, Feb 10, 2022 at 05:33 PM
Greenwich LifeSciences Inc (GLSI:NASDAQ) shot up at $24.28, a gain of 18.8%. On Wed, Feb 09, 2022, GLSI:NASDAQ touched a New 2-Week Intraday High of $21.17. The stock appeared on our News Catalysts scanner on Thu, Feb 03, 2022 at 06:42 AM in the 'MISCELLANEOUS' category. From Thu, Jan 27, 2022, the stock recorded 55.56% Up Days and 50.00% Green Days
About Greenwich LifeSciences Inc (GLSI:NASDAQ)
Greenwich LifeSciences Inc is a clinical stage bio-pharmaceutical company focused on the development of an immunotherapy to prevent breast cancer recurrences in patients.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 32.71%
- Hudson Capital Inc. (HUSN:NASDAQ), 24.48%
- Vaccinex, Inc. (VCNX:NASDAQ), 24.36%
- China Online Education Group (COE:NYSE), 24.04%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 23.68%
- IronNet Inc. (IRNT:NYSE), 23.08%
- Meten EdtechX Education Group Ltd. (METX:NASDAQ), 20.92%
- Live Ventures Incorporated (LIVE:NASDAQ), 19.81%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 18.79%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 17.77%